197 results
Page 8 of 10
8-K
EX-99.1
kygvhi9utke9t1lt1c
2 Aug 06
Discovery Labs Reports Second Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
mk7ws6 ga
27 Jun 06
Discovery Labs Reports Progress on its Surfactant Manufacturing Remediation
12:00am
8-K
EX-99.1
ugn6ynwxlt2 z2p
22 Jun 06
Discovery Labs Retains Jefferies & Company to Assist in the Evaluation of Potential Strategic Alternatives
12:00am
8-K
EX-99.1
4jh3f hwjemct22n1ns
16 Jun 06
Discovery Labs’ SurfaxinÒ Granted Orphan Drug Designation for the Prevention of Bronchopulmonary Dysplasia
12:00am
8-K
EX-99.1
qakw85jrbvh4ydu74
7 Jun 06
Other Events
12:00am
424B3
fqppt6c117iq7z6
12 May 06
Prospectus supplement
12:00am
8-K
EX-99.1
vui17x2tkwc2 629oxh
4 May 06
Discovery Labs Announces Corporate Reorganization and Personnel Reduction
12:00am
8-K
EX-99.1
ucshzeegw2g ym
26 Apr 06
Discovery Labs Reports Surfaxin Manufacturing Issue
12:00am
8-K
EX-99.1
897zm4t4b y4mzl
21 Apr 06
Discovery Labs Secures $50 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
9su jocjmc3o96q5i
5 Apr 06
Discovery Labs Receives Second Approvable Letter from FDA
12:00am
8-K
EX-99.1
xc397 y94t89
31 Mar 06
Discovery Labs Announces Preliminary Results of Phase 2 Clinical Trial in ARDS
12:00am
8-K
EX-99.1
iky1aug0b1wuhj
1 Mar 06
Discovery Labs Reports Fourth Quarter 2005 Financial Results
12:00am
8-K
EX-99.1
fva50dlgymyd
30 Jan 06
Other Events
12:00am
8-K
EX-99.1
d5g0v
3 Jan 06
Represents strategic decision to control manufacturing of Surfaxinâ and SRT pipeline
12:00am
8-K
EX-99.1
lj2ud
20 Dec 05
Discovery Labs Announces Completion of $20.0 Million Registered Direct Offering
12:00am
8-K
EX-99.1
mzykoyxhae8yexn
14 Dec 05
Discovery Labs to Raise $20.0 Million in Registered Direct Offering
12:00am
424B5
yrf36f1g77jpl5ov 7w
14 Dec 05
Prospectus supplement for primary offering
12:00am